Multiple Sclerosis Advisor – Neurology Advisor
Neurology Advisor |
Multiple Sclerosis Advisor
Neurology Advisor Researchers recently published the 5-year results of the HALT-MS study, reporting that 69% of patients who received high-dose immunosuppressive therapy after autologous hematopoietic stem cell transplant (HDIT/HCT) experienced no disability … |
